Publications by authors named "Francesco Angrilli"

Claim this Profile
I
IELSG38: phase II trial of front-line chlorambucil plus subcutaneous rituximab induction and maintenance in mucosa-associated lymphoid tissue lymphoma.
Anastasios Stathis, Maria Cristina Pirosa, Lorella Orsucci, Pierre Feugier, Monica Tani, Francesco Angrilli

Haematologica· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term results of the MCL01 phase II trial of rituximab plus HyperCVAD alternating with high-dose cytarabine and methotrexate for the initial treatment of patients with mantle cell lymphoma.
Fulvio Massaro, Yana Stepanishyna, Martina Manni, Stefano Luminari, Sara Galimberti, Francesco Angrilli

Br J Haematol· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nonpeghylated liposomal doxorubicin combination regimen (R-COMP) for the treatment of lymphoma patients with advanced age or cardiac comorbidity.
Luigi Rigacci, Ombretta Annibali, Sofya Kovalchuk, Elisabetta Bonifacio, Francesca Pregnolato, Francesco Angrilli

Hematol Oncol· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Atypical Presentation of COVID-19 Incidentally Detected at 18F-FDG PET/CT in an Asymptomatic Oncological Patient.
Maria Vittoria Mattoli, Silvia Taralli, Elsa Pennese, Carla D'Angelo, Francesco Angrilli

Clin Nucl Med· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prolonged survival in the absence of disease-recurrence in advanced-stage follicular lymphoma following chemo-immunotherapy: 13-year update of the prospective, multicenter randomized GITMO-IIL trial.
Riccardo Bruna, Fabio Benedetti, Carola Boccomini, Caterina Patti, Anna Maria Barbui, Francesco Angrilli

Haematologica· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MYC protein expression scoring and its impact on the prognosis of aggressive B-cell lymphoma patients.
Maria R Ambrosio, Stefano Lazzi, Giuseppe Lo Bello, Raffaella Santi, Leonardo Del Porro, Francesco Angrilli

Haematologica· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunoglobulin heavy chain variable region gene and prediction of time to first treatment in patients with chronic lymphocytic leukemia: Mutational load or mutational status? Analysis of 1003 cases.
Fortunato Morabito, Tait D Shanafelt, Massimo Gentile, Gianluigi Reda, Francesca Romana Mauro, Francesco Angrilli

Am J Hematol· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Validation of a biological score to predict response in chronic lymphocytic leukemia patients treated front-line with bendamustine and rituximab.
Massimo Gentile, Tait D Shanafelt, Gianluigi Reda, Francesca Romana Mauro, Katja Zirlik, Francesco Angrilli

Leukemia· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predictive value of the CLL-IPI in CLL patients receiving chemo-immunotherapy as first-line treatment.
Massimo Gentile, Tait D Shanafelt, Francesca Romana Mauro, Gianluigi Reda, Davide Rossi, Francesco Angrilli

Eur J Haematol· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-Term Results of the FOLL05 Trial Comparing R-CVP Versus R-CHOP Versus R-FM for the Initial Treatment of Patients With Advanced-Stage Symptomatic Follicular Lymphoma.
Stefano Luminari, Angela Ferrari, Martina Manni, Alessandra Dondi, Annalisa Chiarenza, Francesco Angrilli

J Clin Oncol· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combination of rituximab and nonpegylated liposomal doxorubicin (R-NPLD) as front-line therapy for aggressive non-Hodgkin lymphoma (NHL) in patients 80 years of age or older: a single-center retrospective study.
Giuseppina Ricciuti, Erica Finolezzi, Stefania Luciani, Elena Ranucci, Massimo Federico, Francesco Angrilli

Hematol Oncol· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Whole-brain radiotherapy or autologous stem-cell transplantation as consolidation strategies after high-dose methotrexate-based chemoimmunotherapy in patients with primary CNS lymphoma: results of the second randomisation of the International Extranodal Lymphoma Study Group-32 phase 2 trial.
Andrés J M Ferreri, Kate Cwynarski, Elisa Pulczynski, Christopher P Fox, Elisabeth Schorb, Francesco Angrilli

Lancet Haematol· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Multicenter Phase II Study of Twice-Weekly Bortezomib plus Rituximab in Patients with Relapsed Follicular Lymphoma: Long-Term Follow-Up.
Alessia Bari, Raffaella Marcheselli, Luigi Marcheselli, Isabel Alvarez, Samantha Pozzi, Francesco Angrilli

Acta Haematol· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The chronic lymphocytic leukemia international prognostic index predicts time to first treatment in early CLL: Independent validation in a prospective cohort of early stage patients.
Stefano Molica, Tait D Shanafelt, Diana Giannarelli, Massimo Gentile, Rosanna Mirabelli, Francesco Angrilli

Am J Hematol· November 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combination of bendamustine and rituximab as front-line therapy for patients with chronic lymphocytic leukaemia: multicenter, retrospective clinical practice experience with 279 cases outside of controlled clinical trials.
Massimo Gentile, Katja Zirlik, Stefania Ciolli, Francesca R Mauro, Nicola Di Renzo, Francesco Angrilli

Eur J Cancer· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-Term Results of the HD2000 Trial Comparing ABVD Versus BEACOPP Versus COPP-EBV-CAD in Untreated Patients With Advanced Hodgkin Lymphoma: A Study by Fondazione Italiana Linfomi.
Francesco Merli, Stefano Luminari, Paolo G Gobbi, Nicola Cascavilla, Caterina Mammi, Francesco Angrilli

J Clin Oncol· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prospective validation of predictive value of abdominal computed tomography scan on time to first treatment in Rai 0 chronic lymphocytic leukemia patients: results of the multicenter O-CLL1-GISL study.
Massimo Gentile, Giovanna Cutrona, Stefano Molica, Fiorella Ilariucci, Francesca R Mauro, Francesco Angrilli

Eur J Haematol· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The genotype of MLH1 identifies a subgroup of follicular lymphoma patients who do not benefit from doxorubicin: FIL-FOLL study.
Davide Rossi, Alessio Bruscaggin, Piera La Cava, Sara Galimberti, Elena Ciabatti, Francesco Angrilli

Haematologica· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cometary science. The morphological diversity of comet 67P/Churyumov-Gerasimenko.
Nicolas Thomas, Holger Sierks, Cesare Barbieri, Philippe L Lamy, Rafael Rodrigo, Francesco Angrilli

Science· January 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cometary science. On the nucleus structure and activity of comet 67P/Churyumov-Gerasimenko.
Holger Sierks, Cesare Barbieri, Philippe L Lamy, Rafael Rodrigo, Detlef Koschny, Francesco Angrilli

Science· January 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cometary science. Dust measurements in the coma of comet 67P/Churyumov-Gerasimenko inbound to the Sun.
Alessandra Rotundi, Holger Sierks, Vincenzo Della Corte, Marco Fulle, Pedro J Gutierrez, Francesco Angrilli

Science· January 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prospective validation of a risk score based on biological markers for predicting progression free survival in Binet stage A chronic lymphocytic leukemia patients: results of the multicenter O-CLL1-GISL study.
Massimo Gentile, Giovanna Cutrona, Laura Mosca, Serena Matis, Sonia Fabris, Francesco Angrilli

Am J Hematol· July 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hairy cell leukaemia and venous thromboembolism: a case report and review of the literature.
Natale Vazzana, Raffaele Spadano, Simona Sestili, Valentina Toto, Simona Falorio, Francesco Angrilli

Blood Transfus· April 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fludarabine plus alemtuzumab (FA) front-line treatment in young patients with chronic lymphocytic leukemia (CLL) and an adverse biologic profile.
Francesca R Mauro, Stefano Molica, Luca Laurenti, Agostino Cortelezzi, Angelo M Carella, Francesco Angrilli

Leuk Res· February 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Total body computed tomography scan in the initial work-up of Binet stage A chronic lymphocytic leukemia patients: Results of the prospective, multicenter O-CLL1-GISL study.
Massimo Gentile, Giovanna Cutrona, Sonia Fabris, Emanuela Anna Pesce, Luca Baldini, Francesco Angrilli

Am J Hematol· July 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis